Apr 22, 2014
Novartis and GSK to join forces in consumer healthcare, while Pfizer thought to be considering a $100bn bid for AstraZeneca
Apr 21, 2014
Pfizer Inc. (PFE), the world’s biggest drugmaker, held informal, now-discontinued talks with AstraZeneca Plc about possibly buying the London-based maker of asthma and heart drugs, said two people familiar with the matter.
Apr 17, 2014
The firm's consumer and medical-device group are lagging, but strong results from the pharmaceuticals side should drive earnings throughout this year and into 2015, says Morningstar's Damien Conover.
Apr 16, 2014
GlaxoSmithKline (GSK) has received approval from the US Food and Drug Administration (FDA) for its Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adult patients with type 2 diabetes.
Apr 14, 2014
A sharp drop in the number of young women infected with the two strains of human papillomavirus (HPV) most likely to cause cervical cancer occurred in England after the 2008 launch of a national vaccination program there, a new study shows.
Apr 08, 2014
Merck Serono, the biopharmaceutical division of Merck, announced that its U.S. affiliate EMD Serono has signed a research agreement with Pfizer Inc. and the Broad Institute in Cambridge, Massachusetts, U.S.
Mar 28, 2014
Plans for a new type of DNA vaccine to protect against the deadly HIV and Hepatitis C viruses have taken an important step forward, with University of Adelaide researchers applying for a patent based on groundbreaking new research.
Mar 17, 2014
The need for fresh pharmaceutical sales representatives will increase, along with the increase in sales growth for new pharmaceuticals that are in the market.
Mar 05, 2014
GSK and J&J have released a new AIDS drug to transform the outlook of the disease. New pharmaceutical candidates will be needed for proper promotion of these products to various markets.
Feb 27, 2014
Researchers at the University of Illinois at Chicago have developed a system for precisely delivering anti-inflammatory drugs to immune cells gone out of control, while sparing their well-behaved counterparts.